Federal contract award
75A50120C00009
CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541713 — Research and Development in Nanotechnology |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $19.3M |
| Current contract value | $19.3M |
| Potential contract value / ceiling | $159.1M |
| Start date | Mar 19, 2020 |
| Current end date | Jul 31, 2023 |
| Potential end date | Jul 31, 2023 |
| Latest award activity | Jun 10, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 10, 2026 | P00016 | $-455.9K | THIS MODIFICATION DE-OBLIGATES CANCELING YEAR FUNDS FROM REQUISITION OS251050 IN THE AMOUNT OF $(200,285.24) AND FROM REQUISITION OS272235 IN THE AMOUNT OF $(255,619.91) FROM BASE/CLIN0001. THE CONTRACT TOTAL AMOUNT IS DECREASED BY $(455,905.15) |
| Sep 9, 2025 | P00015 | $-428.8K | THIS MODIFICATION DE-OBLIGATES CANCELING YEAR FUNDS FROM REQUISITION OS251050 IN THE AMOUNT OF $428,800.23 FROM BASE/CLIN0001, UPDATE ARTICLES F.2. DELIVERABLES, G.1. CONTRACTING OFFICER, G.2. CONTRACTING OFFICER?S REPRESENTATIVE, AND G.5. INVOICE/FI |
| Aug 15, 2025 | P00014 | $0 | CMC EFFORTS FOR MAB114 FOR THE DEVELOPMENT AND TREATMENT OF EBOLA. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.